Cargando…

Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1

Diabetes is characterized by chronic hyperglycemia, which in turn facilitates the formation of advanced glycation end products (AGEs). AGEs activate signaling proteins such as Src, Akt and ERK1/2. However, the mechanisms by which AGEs activate these kinases remain unclear. We examined the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Su-Jung, Chen, Chen-Yu, Chang, Geen-Dong, Wen, Hui-Chin, Chen, Ching-Yu, Chang, Shi-Chuan, Liao, Jyh-Fei, Chang, Chung-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589465/
https://www.ncbi.nlm.nih.gov/pubmed/23472139
http://dx.doi.org/10.1371/journal.pone.0058100
_version_ 1782261740508020736
author Yang, Su-Jung
Chen, Chen-Yu
Chang, Geen-Dong
Wen, Hui-Chin
Chen, Ching-Yu
Chang, Shi-Chuan
Liao, Jyh-Fei
Chang, Chung-Ho
author_facet Yang, Su-Jung
Chen, Chen-Yu
Chang, Geen-Dong
Wen, Hui-Chin
Chen, Ching-Yu
Chang, Shi-Chuan
Liao, Jyh-Fei
Chang, Chung-Ho
author_sort Yang, Su-Jung
collection PubMed
description Diabetes is characterized by chronic hyperglycemia, which in turn facilitates the formation of advanced glycation end products (AGEs). AGEs activate signaling proteins such as Src, Akt and ERK1/2. However, the mechanisms by which AGEs activate these kinases remain unclear. We examined the effect of AGEs on Akt activation in 3T3-L1 preadipocytes. Addition of AGEs to 3T3-L1 cells activated Akt in a dose- and time-dependent manner. The AGEs-stimulated Akt activation was blocked by a PI3-kinase inhibitor LY 294002, Src inhibitor PP2, an antioxidant NAC, superoxide scavenger Tiron, or nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase inhibitor DPI, suggesting the involvement of Src and NAD(P)H oxidase in the activation of PI3-kinase-Akt pathway by AGEs. AGEs-stimulated Src tyrosine phosphorylation was inhibited by NAC, suggesting that Src is downstream of NAD(P)H oxidase. The AGEs-stimulated Akt activity was sensitive to Insulin-like growth factor 1 receptor (IGF-1R) kinase inhibitor AG1024. Furthermore, AGEs induced phosphorylation of IGF-1 receptorβsubunit (IGF-1Rβ) on Tyr1135/1136, which was sensitive to PP2, indicating that AGEs stimulate Akt activity by transactivating IGF-1 receptor. In addition, the AGEs-stimulated Akt activation was attenuated by β-methylcyclodextrin that abolishes the structure of caveolae, and by lowering caveolin-1 (Cav-1) levels with siRNAs. Furthermore, addition of AGEs enhanced the interaction of phospho-Cav-1 with IGF-1Rβ and transfection of 3T3-L1 cells with Cav-1 Y14F mutants inhibited the activation of Akt by AGEs. These results suggest that AGEs activate NAD(P)H oxidase and Src which in turn phosphorylates IGF-1 receptor and Cav-1 leading to activation of IGF-1 receptor and the downstream Akt in 3T3-L1 cells. AGEs treatment promoted the differentiation of 3T3-L1 preadipocytes and addition of AG1024, LY 294002 or Akt inhibitor attenuated the promoting effect of AGEs on adipogenesis, suggesting that IGF-1 receptor, PI3-Kinase and Akt are involved in the facilitation of adipogenesis by AGEs.
format Online
Article
Text
id pubmed-3589465
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35894652013-03-07 Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1 Yang, Su-Jung Chen, Chen-Yu Chang, Geen-Dong Wen, Hui-Chin Chen, Ching-Yu Chang, Shi-Chuan Liao, Jyh-Fei Chang, Chung-Ho PLoS One Research Article Diabetes is characterized by chronic hyperglycemia, which in turn facilitates the formation of advanced glycation end products (AGEs). AGEs activate signaling proteins such as Src, Akt and ERK1/2. However, the mechanisms by which AGEs activate these kinases remain unclear. We examined the effect of AGEs on Akt activation in 3T3-L1 preadipocytes. Addition of AGEs to 3T3-L1 cells activated Akt in a dose- and time-dependent manner. The AGEs-stimulated Akt activation was blocked by a PI3-kinase inhibitor LY 294002, Src inhibitor PP2, an antioxidant NAC, superoxide scavenger Tiron, or nicotinamide adenine dinucleotide phosphate (NAD(P)H) oxidase inhibitor DPI, suggesting the involvement of Src and NAD(P)H oxidase in the activation of PI3-kinase-Akt pathway by AGEs. AGEs-stimulated Src tyrosine phosphorylation was inhibited by NAC, suggesting that Src is downstream of NAD(P)H oxidase. The AGEs-stimulated Akt activity was sensitive to Insulin-like growth factor 1 receptor (IGF-1R) kinase inhibitor AG1024. Furthermore, AGEs induced phosphorylation of IGF-1 receptorβsubunit (IGF-1Rβ) on Tyr1135/1136, which was sensitive to PP2, indicating that AGEs stimulate Akt activity by transactivating IGF-1 receptor. In addition, the AGEs-stimulated Akt activation was attenuated by β-methylcyclodextrin that abolishes the structure of caveolae, and by lowering caveolin-1 (Cav-1) levels with siRNAs. Furthermore, addition of AGEs enhanced the interaction of phospho-Cav-1 with IGF-1Rβ and transfection of 3T3-L1 cells with Cav-1 Y14F mutants inhibited the activation of Akt by AGEs. These results suggest that AGEs activate NAD(P)H oxidase and Src which in turn phosphorylates IGF-1 receptor and Cav-1 leading to activation of IGF-1 receptor and the downstream Akt in 3T3-L1 cells. AGEs treatment promoted the differentiation of 3T3-L1 preadipocytes and addition of AG1024, LY 294002 or Akt inhibitor attenuated the promoting effect of AGEs on adipogenesis, suggesting that IGF-1 receptor, PI3-Kinase and Akt are involved in the facilitation of adipogenesis by AGEs. Public Library of Science 2013-03-05 /pmc/articles/PMC3589465/ /pubmed/23472139 http://dx.doi.org/10.1371/journal.pone.0058100 Text en © 2013 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Yang, Su-Jung
Chen, Chen-Yu
Chang, Geen-Dong
Wen, Hui-Chin
Chen, Ching-Yu
Chang, Shi-Chuan
Liao, Jyh-Fei
Chang, Chung-Ho
Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title_full Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title_fullStr Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title_full_unstemmed Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title_short Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
title_sort activation of akt by advanced glycation end products (ages): involvement of igf-1 receptor and caveolin-1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589465/
https://www.ncbi.nlm.nih.gov/pubmed/23472139
http://dx.doi.org/10.1371/journal.pone.0058100
work_keys_str_mv AT yangsujung activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT chenchenyu activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT changgeendong activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT wenhuichin activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT chenchingyu activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT changshichuan activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT liaojyhfei activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1
AT changchungho activationofaktbyadvancedglycationendproductsagesinvolvementofigf1receptorandcaveolin1